NewGenIVF Group Ltd. (NIVF) Stock Price, Financials & Summary

Price chart

Sep 30Oct 5Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29

Key dataOct 29, 2026

Open$1.13

From 52W high−99.99%

Volume253256.00

Market cap$11.28M

P/E (TTM)0.0x

P/S (TTM)2.4x

Div yield—

Key dataOct 29, 2026

Open

$1.13

From 52W high

−99.99%

Volume

253256.00

Market cap

$11.28M

ValuationView details →

P/E (Fwd)

0.0x

EV/EBITDA

1.0x

P/E (TTM)

0.0x

RSI (14)

32.2

MomentumView details →

1D Return

−5.00%

YTD Return

−99.95%

SummaryUpdated Jun 1, 2026

NewGenIVF Group Limited (NASDAQ:NIVF) is a Thailand-based assisted reproductive services provider that went public in March 2022. Founded to address the growing demand for fertility treatments in Southeast Asia, the company operates fertility clinics primarily in Thailand and has expanded its services to help couples and individuals build families through advanced reproductive technologies. Since its IPO, the company has faced significant operational and financial challenges while attempting to establish itself in the competitive fertility treatment market.

Ask drillr about NewGenIVF Group Ltd. →

ValuationView details →

P/E (Fwd)

0.0x

P/E (TTM)

0.0x

EV/EBITDA

1.0x

EV/Sales

2.4x

P/S (TTM)

2.4x

P/B (TTM)

0.4x

ProfitabilityView details →

Gross Margin

20.22%

Net Margin

209.02%

EBITDA Margin

229.45%

ROE (TTM)

37.38%

ROA (TTM)

27.11%

Asset Turnover

0.14x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

−7.36%

EPS CAGR 3Y

+112.55%

EBITDA YoY

—

MomentumView details →

1D Return

−5.00%

YTD Return

−99.95%

1Y Return

−99.99%

RSI (14)

32.2

vs 50D SMA

−79.82%

vs 200D SMA

−99.71%

Capital & dividendView details →

Debt/Equity

0.06x

Current Ratio

1.06x

Quick Ratio

1.03x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

$18.18

EPS Surprise

0.00%

Beats (12Q)

0/12

Next Q EPS Est

$53,395.20

Avg Surprise (4Q)

−50.54%

Rev Surprise

0.00%

Financials snapshotView financials →

Revenue (TTM)

1.93B

Net Income (TTM)

−8.03B

Op. CF (TTM)

—

Next earningsMar 3, 2027 →

Latest newsMore news →

NewGenIvf Group Limited closed a previously announced public offering with gross proceeds of approximately $1.25 million.29d ago

NewGenIvf Group Limited priced a public offering of its securities on a reasonable best efforts basis, expecting gross proceeds of approximately $1.25 million.31d ago

Similar companies

Caring Brands, Inc.CABR Basel Medical Group Ltd Ordinary SharesBMGL Sipai Health Technology Co., Ltd.00314.HK Alignment Healthcare, Inc.ALHC Clover Health Investments, Corp.CLOV Oscar Health, Inc.OSCR Find similar companies →

Latest newsMore news →

NewGenIvf Group Limited closed a previously announced public offering with gross proceeds of approximately $1.25 million.29d ago NewGenIvf Group Limited priced a public offering of its securities on a reasonable best efforts basis, expecting gross proceeds of approximately $1.25 million.31d ago NewGenIVF Group Limited completed an exchange of existing convertible notes held by an institutional investor for a new senior convertible note on amended terms, closing on August 14, 2026.73d ago